A clinical trial conducted by researchers at the University of Utah Health found that radiofrequency catheter ablation lowered hospitalization and mortality rates by 47% and 44%, respectively, in patients with atrial fibrillation. The study suggests that catheter ablation may be a more effective treatment option than traditional drug t...
A NUS study found a strong association between deforestation in Cambodia and increased risk of diarrhoea, acute respiratory infections, and fever in children under five. The study suggests that conserving forests could help mitigate health burdens and inform policy decisions on land use planning.
A research team led by Professor Bhesh Bhandari has discovered that small fat globules can impart stability to cream and give cold butter a softer texture. The breakthrough uses nanoemulsions to create innovative dairy ingredients with potential to increase the return on investment for dairy manufacturers.
A new study found that using two anticlotting medicines instead of three can reduce the risk of major bleeding in patients with atrial fibrillation who have had a stent placed. The RE-DUAL PCI trial showed that dabigatran, combined with either clopidogrel or ticagrelor, cut the risk of bleeding by half compared to standard triple therapy.
A new study found that higher coffee consumption is associated with a lower risk of death, particularly among those aged 45 and above. Drinking four cups of coffee per day was linked to a 64% reduced risk of all-cause mortality.
A major international study found that combining two drugs, rivaroxaban and aspirin, is superior to aspirin alone in preventing further heart complications in people with vascular disease. The combination reduced strokes, heart attacks, and cardiovascular death by practically 25% compared to either drug alone.
Tropical Storm Harvey showed powerful storms that could produce heavy rainfall, with cloud top temperatures as cold as minus 63 degrees Fahrenheit. The storms were detected by NASA's Aqua satellite and identified areas extending from southeastern Texas into southeastern Louisiana.
A new study has confirmed the safety and efficacy of a rapid algorithm to rule-out and rule-in myocardial infarction. The algorithm uses high-sensitivity cardiac troponin blood concentrations to diagnose patients with acute chest pain, allowing for quicker triage and early initiation of evidence-based therapy.
The CANTOS trial found that canakinumab significantly reduced the risk of cardiovascular events and total cancer death, with dose-dependent effects on lung cancer rates. The study showed a 15% reduction in cardiovascular event risk and a 17% reduction in hospitalization for unstable angina.
A new study, CASTLE-AF, shows that catheter ablation significantly improves outcomes for patients with left ventricular dysfunction and atrial fibrillation. The treatment reduces the risk of stroke, blood clots, and heart failure in these patients.
The COMPASS trial found that the combination of rivaroxaban and aspirin reduces major adverse cardiovascular and limb events by 31%, lowering cardiovascular death, stroke or heart attack by 28% and limb-threatening ischaemia by 46%. Rivaroxaban alone does not reduce major adverse cardiovascular events but lowers major adverse limb events.
The RACE 3 trial found that risk factor-driven upstream rhythm control is effective in improving maintenance of sinus rhythm in patients with early short-lasting AF and heart failure. Sinus rhythm was present in 75% of patients in the upstream therapy group compared to 63% in the control group.
Scientists at King Abdullah University of Science & Technology (KAUST) have discovered a crystalline material that changes shape in response to light, showcasing its potential applications in novel optoelectronic devices
The COMPASS trial found that combining rivaroxaban and aspirin improved survival by 18% and reduced cardiovascular death, stroke, or heart attack by 24%. The treatment also increased bleeding risk but showed significant net benefits for patients.
A study by Progetto Vita found that 93% of patients treated with an onsite AED survived cardiac arrest, compared to just 9% without an AED. The presence of an AED significantly reduced response times and improved survival rates.
A new study published in the European Society of Cardiology found that high salt intake is associated with a doubled risk of heart failure. The study, which followed over 4,000 participants for 12 years, estimated individual salt intake using a 24-hour sodium extraction method.
Research suggests PCSK9 plays a role in platelet activation and aggregation, with higher levels linked to increased platelet reactivity. PCSK9 inhibitors may also reduce thrombosis by interfering with platelet function.